schizoidman@lemmy.zip to World News@lemmy.worldEnglish · 3 days agoAstraZeneca to license lung cancer drug from China's Dizal Pharmaceuticalwww.reuters.comexternal-linkmessage-square4linkfedilinkarrow-up131arrow-down10 cross-posted to: globalnews@lemmy.zip
arrow-up131arrow-down1external-linkAstraZeneca to license lung cancer drug from China's Dizal Pharmaceuticalwww.reuters.comschizoidman@lemmy.zip to World News@lemmy.worldEnglish · 3 days agomessage-square4linkfedilink cross-posted to: globalnews@lemmy.zip
minus-squarefullsquarelinkfedilinkEnglisharrow-up2·edit-23 days agothere are drug trials that cost more money than that. also this is not +4 months comparison new drug vs nothing this is new drug vs old drug. if AZ also got their IP then it’s a fire sale here is study: https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA8500
there are drug trials that cost more money than that. also this is not +4 months comparison new drug vs nothing this is new drug vs old drug. if AZ also got their IP then it’s a fire sale
here is study: https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA8500